U.S. Urology Devices Market, By Product Type (Dialysis Equipment, Urinary Stone Treatment Devices, Endoscopy Devices, Benign Prostatic Hyperplasia Treatment Devices, Urinary Incontinence & Pelvic Organ Prolapsed and Other Products), Type (Instruments and Consumables & Accessories), Indication (Kidney Diseases, Overactive Bladder, Hematuria, Urinary Tract Infection, Kidney Stones, Premature Ejaculation, Benign Prostatic Hyperplasia, Urological Cancer, Pelvic Organ Prolapse, Urethrotomies, Urethral Stricture and Other Disease), Technology (Minimally Invasive Surgery, Robotic Surgery and Others), End User (Hospitals & Clinics, Dialysis Centers, Clinical Research Laboratories, Academic Institutes and Others), Distribution Channel (Direct Tenders, Third Party Distribution and Others), Country (U.S.) Industry Trends & Forecast to 2029.
Market Analysis and Insights: U.S. Urology Devices Market
The U.S. urology devices market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 10.3% in the forecast period of 2022 to 2029 and is expected to reach USD 16,249.70 million by 2029. Rising healthcare expenditure and increased interest towards minimally invasive surgery act as driver for the urology devices market growth.
Urology devices and supplies are products that are designed for people who have urologic diseases, urinary retention and need help removing urine from the body. Urologic diseases or conditions include urinary tract infections, kidney stones, bladder control problems and prostate problems and more. Urology devices includes wide range of products such as urology operating tables, urological examination tables, chairs, urology ultrasound imaging systems, bladder scanners, urodynamic systems, urinary flow meters, intra corporeal lithotripters, extra corporeal lithotripters, urological lasers, urology forceps, prostate biopsy needles, meshes, stents, catheters, drainage sets and bags, stimulators, probes, cancer test kits and implants. These devices are used for both diagnosis and urology treatment procedures. Common urology procedures that are done includes vasectomy, vasectomy reversal, cystoscopy, prostate procedure, lithotripsy and among more. Some urologic conditions last only short time while others are long lasting. Common symptoms in urology problems are difficulty urinating, pain or burning while urinating, blood or other discharge in urine, fever, chills, lower back pain and pain in genitals.
The U.S. urology devices market is growing in the forecast year due to the rise in market players and the availability of advanced products owing to the increasing incidence of urology conditions. Along with this, manufacturers are engaged in R&D activity for launching novel products in the market with successful product approvals. However, the high cost of urology devices and lack of awareness about urological treatment and devices with product recalls may hamper the growth of the U.S. urology devices market in the forecast period.
The rising healthcare expenditure and increased interest towards minimally invasive surgery are opportunities for the market growth. The strategic initiatives by market players are giving further opportunity to the market to enhance the treatment. However, the lack of skilled professionals and stringent regulatory framework are challenging the market growth.
The urology devices market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the urology devices market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Urology Devices Market Scope and Market Size
The U.S. urology devices market is segmented on basis of product type, type, indication, technology, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product type, the U.S. urology devices market is segmented into dialysis equipment, urinary stone treatment devices, endoscopy devices, benign prostatic hyperplasia treatment devices, urinary incontinence & pelvic organ prolapsed and other products. In 2022, dialysis equipment segment is expected to dominate the market due to increasing prevalence of kidney failure cases among geriatric population.
- On the basis of type, the U.S. urology devices market is segmented into instruments and consumables and accessories. In 2022, instruments segment is expected to dominate the market due to increasing research activities and market players in the country.
- On the basis of indication, the U.S. urology devices market is segmented into kidney diseases, overactive bladder, hematuria, urinary tract infection, kidney stones, premature ejaculation, benign prostatic hyperplasia, urological cancer, pelvic organ prolapse, urethrotomies, urethral stricture and other disease. In 2022, kidney diseases segment is expected to dominate the market due to rising geriatric population and high diabetes cases in the country.
- On the basis of technology, the U.S. urology devices market is segmented into minimally invasive surgery, robotic surgery and others. In 2022, minimally invasive surgery segment is expected to dominate the market as they are more advanced and highly preferred.
- On the basis of end user, the U.S. urology devices market is segmented into hospitals & clinics, dialysis centers, clinical research laboratories, academic institutes and others. In 2022, hospitals & clinics segment is expected to dominate the market as the number of hospitals with advanced urological procedures are high in the country.
- On the basis of distribution channel, the U.S. urology devices market is segmented into direct tenders, third party distribution and others. In 2022, direct tenders segment is expected to dominate the market as the channel provides best products directly from the manufacturing unit.
Urology devices Market Country Level Analysis
The urology devices market is analyzed and market size information is provided by the country, product type, type, indication, technology, end user and distribution channel as referenced above.
The countries covered in the urology devices market report are the U.S.
U.S is expected to grow with the highest growth rate in the forecast period of 2022 to 2029 because of increasing prevalence of urologic conditions.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of U.S. brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Growing Strategic Activities by Major Market Players to Enhance the Awareness for Urology Devices Treatment, is Boosting the Market Growth of Urology Devices Market.
The urology devices market also provides you with detailed market analysis for every country growth in particular market. Additionally, it provides the detail information regarding the market players’ strategy and their geographical presence. The data is available for historic period 2011 to 2020.
Competitive Landscape and Urology Devices Market Share Analysis
Urology devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to urology devices market.
The major companies which are dealing in the urology devices are Medtronic, Siemens, CooperSurgical, Inc., General Electric, BD, Stryker, Boston Scientific Corporation, Cardinal Health., Intuitive Surgical., Cook, Olympus Corporation, Med pro Medical B.V., Fresenius Medical Care AG & Co. KGaA, Baxter., Richard Wolf GmbH., Dornier MedTech., KARL STORZ SE & Co. Kg, Dale Medical Products, Inc., Healthtronics, Inc., Medi Tech Devices Pvt. Ltd., Coloplast Corp., Remington MEDICAL, Medi-Globe GmbH, Nikkiso Co., Ltd., B. Braun Melsungen AG, Lumenis Be Ltd., Teleflex Incorporated, Urocare Products, Inc., Dynarex Corporation and among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many contract and agreement are also initiated by the companies’ worldwide which are also accelerating the urology devices market.
For instance,
- In January, 2022, Stryker (U.S.) acquired Vocera Communications (U.S) which is a leader in the digital care coordination and communication category. This acquisition helped company in expanding the innovative portfolio of Stryker’s Medical division propelling the market growth.
- In October, 2021, Medtronic announced that the company received CE mark for their urologic product “Hugo robotic-assisted surgery (RAS) system” which is authorized for sale in Europe. The CE mark approval increased the products quality in urologic and gynecologic procedures which make up about half of all robotic procedures performed today. This improved company’s position over market
- In November, 2020, Coloplast Corp. announced that the company acquired Nine Continents Medical, Inc. which is an early stage company pioneering an implantable tibial nerve stimulation treatment for over-active bladder. This acquisition helped company in improving opportunities over interventional urology business to bring innovative solutions to the market.
Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market player is enhancing the company footprints in the veterinary infusion pumps market which also provides the benefit for organization’s profit growth.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF U.S. UROLOGY DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET INDICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 GLOBAL MEDICAL DEVICES GROWTH TRENDS - OVERVIEW
4.2 PESTEL
4.3 PORTER'S FIVE FORCES MODEL
5 U.S. UROLOGY DEVICES MARKET: REGULATIONS
5.1 U.S.
5.2 EUROPE
5.3 GERMANY
5.4 ITALY
5.5 SPAIN
5.6 RUSSIA
5.7 NETHERLANDS
5.8 SWITZERLAND
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISE IN RESEARCH AND DEVELOPMENT OF UROLOGY MEDICAL DEVICES
6.1.2 RISE IN INCIDENCE OF UROLOGY CONDITIONS IN U.S.
6.1.3 TECHNOLOGICAL ADVANCEMENTS IN UROLOGICAL DEVICES
6.1.4 RISE IN GERIATRIC POPULATION
6.1.5 RISE IN PRODUCT APPROVALS
6.2 RESTRAINTS
6.2.1 RISE IN COST OF UROLOGY DEVICES AND TREATMENT OF UROLOGICAL CONDITIONS
6.2.2 RISKS OBSERVED WHILE USING UROLOGICAL DEVICES
6.2.3 RISE IN PRODUCT RECALL
6.2.4 LACK OF AWARENESS ABOUT TREATMENT FOR UROLOGICAL CONDITIONS
6.3 OPPORTUNITIES/
6.3.1 STRATEGIC INITIATIVE BY MARKET PLAYERS
6.3.2 RISE IN HEALTHCARE EXPENDITURE
6.3.3 INCREASED USE OF MINIMALLY INVASIVE SURGICAL DEVICES
6.4 CHALLENGES
6.4.1 LACK OF SKILLED PROFESSIONALS REQUIRED FOR USE OF UROLOGY DEVICES
6.4.2 STRINGENT REGULATIONS
7 IMPACT OF COVID-19 PANDEMIC ON THE MARKET
7.1 PRICE IMPACT
7.2 IMPACT ON DEMAND
7.3 IMPACT ON SUPPLY CHAIN
7.4 STRATEGIC DECISIONS FOR MANUFACTURERS/ SERVICE PROVIDERS
7.5 CONCLUSION
8 U.S. UROLOGY DEVICES MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 DIALYSIS EQUIPMENT
8.3 URINARY STONE TREATMENT DEVICES
8.4 ENDOSCOPY DEVICES
8.5 URINARY INCONTINENCE & PELVIC ORGAN PROLAPSED
8.6 BENIGN PROSTATIC HYPERPLASIA TREATMENT DEVICES
8.7 OTHER PRODUCTS
9 U.S. UROLOGY DEVICES MARKET, BY TYPE
9.1 OVERVIEW
9.2 INSTRUMENTS
9.2.1 DIALYSIS DEVICES
9.2.1.1 CENTER-USE HEMODIALYSIS MACHINES
9.2.1.2 HOME-USE HEMODIALYSIS MACHINES
9.2.2 LASERS AND LITHOTRIPSY DEVICES
9.2.2.1 UROLOGY LASERS
9.2.2.2 LITHOTRIPTERS
9.2.2.2.1 INTRACORPOREAL LITHOTRIPTERS
9.2.2.2.2 EXTRACORPOREAL LITHOTRIPTERS
9.2.3 ENDOSCOPES AND ENDOVISION SYSTEMS
9.2.4 OTHER INSTRUMENT
9.3 CONSUMABLES AND ACCESSORIES
9.3.1 DIALYSIS CONSUMABLES
9.3.1.1 DIALYZERS
9.3.1.2 HEMODIALYSIS CONCENTRATES
9.3.1.2.1 ACIDIC
9.3.1.2.2 ALKALINE
9.3.1.3 BLOODLINES
9.3.1.4 OTHERS
9.3.2 GUIDEWIRES AND CATHETERS
9.3.2.1 URETERAL CATHETERES
9.3.2.2 NEPHROSTOMY CATHETERES
9.3.2.3 VESICAL CATHETERES
9.3.2.4 CYSTOMETRY CATHETERES
9.3.2.5 RECTAL PRESSURE MONITORING CATHETERS
9.3.2.6 OTHER CATHETERS
9.3.3 STENTS
9.3.3.1 URETHRAL STENTS
9.3.3.2 URETERAL STENTS
9.3.3.3 PROSTATIC STENTS
9.3.4 ENDOSCOPIC BASKETS
9.3.5 BIOPSY DEVICES
9.3.5.1 PROSTATE BIOPSY NEEDLES
9.3.5.2 OTHERS
9.3.6 PELVIC IMPLANTS
9.3.7 MESHES
9.3.8 MORCELLATORS
9.3.9 OTHER CONSUMABLES AND ACCESSORIES
10 U.S. UROLOGY DEVICES MARKET, BY INDICATION
10.1 OVERVIEW
10.2 KIDNEY DISEASES
10.3 KIDNEY STONES
10.4 UROLOGICAL CANCER
10.5 PELVIC ORGAN PROLAPSE
10.6 BENIGN PROSTATIC HYPERPLASIA
10.7 HEMATURIA
10.8 URINARY TRACT INFECTIONS
10.9 URETHROTOMIES
10.1 OVERACTIVE BLADDER
10.11 PREMATURE EJACULATION
10.12 URETHRAL STRICTURE
10.13 OTHER DISEASE
11 U.S. UROLOGY DEVICES MARKET, BY TECHNOLOGY
11.1 OVERVIEW
11.2 MINIMALLY INVASIVE SURGERY
11.3 ROBOTIC SURGERY
11.4 OTHERS
12 U.S. UROLOGY DEVICES MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS & CLINICS
12.3 DIALYSIS CENTERS
12.4 CLINICAL RESEARCH LABORATORIES
12.5 ACADEMIC INSTITUTES
12.6 OTHERS
13 U.S. UROLOGY DEVICES MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDERS
13.3 THIRD PARTY DISTRIBUTORS
13.4 OTHERS
14 U.S. UROLOGY DEVICES MARKET, BY REGION
14.1 U.S.
15 U.S. UROLOGY DEVICES MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: U.S.
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 FRESENIUS SE & CO. KGAA
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENT
17.2 BAXTER
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 PRODUCT PORTFOLIO
17.2.4 RECENT DEVELOPMENT
17.3 BOSTON SCIENTIFIC CORPORATION
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENT
17.4 OLYMPUS CORPORATION
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENTS
17.5 B. BRAUN MELSUNGEN AG
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENT
17.6 BD
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENT
17.7 MEDTRONIC
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENTS
17.8 COOPERSURGICAL INC.
17.8.1 COMPANY SNAPSHOT
17.8.2 REVENUE ANALYSIS
17.8.3 PRODUCT PORTFOLIO
17.8.4 RECENT DEVELOPMENT
17.9 COLOPLAST CORP
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENTS
17.9.5 ACQUISITION
17.1 CARDINAL HEALTH
17.10.1 COMPANY SNAPSHOT
17.10.2 REVENUE ANALYSIS
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENT
17.11 COOK
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENTS
17.12 DORNIER MEDTECH
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 DALE MEDICAL PRODUCTS, INC.
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.13.4 DEVELOPMENT
17.14 DYNAREX CORPORATION
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENTS
17.15 GENERAL ELECTRIC
17.15.1 COMPANY SNAPSHOT
17.15.2 REVENUE ANALYSIS
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENT
17.15.5 ACQUISITION
17.16 HEALTHTRONICS, INC
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENTS
17.16.4 ACQUISITION
17.17 INTUITIVE SURGICAL
17.17.1 COMPANY SNAPSHOT
17.17.2 REVENUE ANALYSIS
17.17.3 PRODUCT PORTFOLIO
17.17.4 RECENT DEVELOPMENT
17.18 KARL STORZ SE & CO KG,TUTTLINGEN
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENT
17.19 LUMENIS BE LTD.
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENTS
17.19.4 PRODUCT LAUNCHES
17.2 MEDI GLOBE GMBH
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENT
17.21 MEDI TECH DEVICES PVT. LTD.
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENT
17.22 MED PRO MEDICAL B.V.
17.22.1 COMPANY SNAPSHOT
17.22.2 PRODUCT PORTFOLIO
17.22.3 RECENT DEVELOPMENT
17.23 NIKKISO CO., LTD.
17.23.1 COMPANY SNAPSHOT
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENT
17.24 REMINGTON MEDICAL
17.24.1 COMPANY SNAPSHOT
17.24.2 PRODUCT PORTFOLIO
17.24.3 RECENT DEVELOPMENT
17.25 RICHARD WOLF GMBH
17.25.1 COMPANY SNAPSHOT
17.25.2 PRODUCT PORTFOLIO
17.25.3 RECENT DEVELOPMENT
17.26 STRYKER
17.26.1 COMPANY SNAPSHOT
17.26.2 REVENUE ANALYSIS
17.26.3 PRODUCT PORTFOLIO
17.26.4 RECENT DEVELOPMENTS
17.26.5 ACQUISITION
17.27 SIEMENS HEALTHCARE GMBH
17.27.1 COMPANY SNAPSHOT
17.27.2 REVENUE ANALYSIS
17.27.3 PRODUCT PORTFOLIO
17.27.4 RECENT DEVELOPMENTS
17.27.5 ACQUISITION
17.28 TELEFLEX INCORPORATED.
17.28.1 COMPANY SNAPSHOT
17.28.2 REVENUE ANALYSIS
17.28.3 PRODUCT PORTFOLIO
17.28.4 RECENT DEVELOPMENTS
17.28.5 PRODUCT LAUNCH
17.29 UROCARE PRODUCTS, INC.
17.29.1 COMPANY SNAPSHOT
17.29.2 PRODUCT PORTFOLIO
17.29.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
List of Table
TABLE 1 U.S. UROLOGY DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 2 U.S. UROLOGY DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 3 U.S. INSTRUMENTS IN UROLOGY DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 4 U.S. DIALYSIS DEVICES IN UROLOGY DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 5 U.S. LASERS AND LITHOTRIPSY DEVICES IN UROLOGY DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 6 U.S. LITHOTRIPTERS IN UROLOGY DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 7 U.S. CONSUMABLES AND ACCESSORIES IN UROLOGY DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 8 U.S. DIALYSIS CONSUMABLES IN UROLOGY DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 9 U.S. HEMODIALYSIS CONCENTRATES IN UROLOGY DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 10 U.S. GUIDEWIRES AND CATHETERS IN UROLOGY DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 11 U.S. STENTS IN UROLOGY DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 12 U.S. BIOPSY DEVICES IN UROLOGY DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 13 U.S. UROLOGY DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 14 U.S. UROLOGY DEVICES MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 15 U.S. UROLOGY DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 16 U.S. UROLOGY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 17 U.S. UROLOGY DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 18 U.S. UROLOGY DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 19 U.S. INSTRUMENTS IN UROLOGY DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 20 U.S. DIALYSIS DEVICES IN UROLOGY DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 21 U.S. LASERS AND LITHOTRIPSY DEVICES IN UROLOGY DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 22 U.S. LITHOTRIPTERS IN UROLOGY DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 23 U.S. CONSUMABLES AND ACCESSORIES IN UROLOGY DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 24 U.S. DIALYSIS CONSUMABLES IN UROLOGY DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 25 U.S. HEMODIALYSIS CONCENTRATES IN UROLOGY DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 26 U.S. GUIDEWIRES AND CATHETERS UROLOGY DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 27 U.S. STENTS IN UROLOGY DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 28 U.S. BIOPSY DEVICES IN UROLOGY DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 29 U.S. UROLOGY DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 30 U.S. UROLOGY DEVICES MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)
TABLE 31 U.S. UROLOGY DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 32 U.S. UROLOGY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 U.S. UROLOGY DEVICES MARKET: SEGMENTATION
FIGURE 2 U.S. UROLOGY DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 U.S. UROLOGY DEVICES MARKET: DROC ANALYSIS
FIGURE 4 U.S. UROLOGY DEVICES MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 U.S. UROLOGY DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 U.S. UROLOGY DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 U.S. UROLOGY DEVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 U.S. UROLOGY DEVICES MARKET: INDICATION COVERAGE GRID
FIGURE 9 U.S. UROLOGY DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 U.S. UROLOGY DEVICES MARKET: SEGMENTATION
FIGURE 11 RISING PREVALENCE OF UROLOGICAL DISORDERS IS EXPECTED TO DRIVE THE U.S. UROLOGY DEVICES MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 DIALYSIS EQUIPMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. UROLOGY DEVICES MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE U.S. UROLOGY DEVICES MARKET
FIGURE 14 ESTIMATED COUNT OF WOMEN SUFFERING FROM URINARY INCONTINENCE IN 2021 IN THE U.S.
FIGURE 15 PROSTATE CANCER INCIDENCE IN EUROPEAN REGION IN 2021
FIGURE 16 U.S. UROLOGY DEVICES MARKET: BY PRODUCT TYPE, 2021
FIGURE 17 U.S. UROLOGY DEVICES MARKET: BY PRODUCT TYPE, 2020-2029 (USD MILLION)
FIGURE 18 U.S. UROLOGY DEVICES MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 19 U.S. UROLOGY DEVICES MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 20 U.S. UROLOGY DEVICES MARKET: BY TYPE, 2021
FIGURE 21 U.S. UROLOGY DEVICES MARKET: BY TYPE, 2020-2029 (USD MILLION)
FIGURE 22 U.S. UROLOGY DEVICES MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 23 U.S. UROLOGY DEVICES MARKET: BY TYPE, LIFELINE CURVE
FIGURE 24 U.S. UROLOGY DEVICES MARKET: BY INDICATION, 2021
FIGURE 25 U.S. UROLOGY DEVICES MARKET: BY INDICATION, 2020-2029 (USD MILLION)
FIGURE 26 U.S. UROLOGY DEVICES MARKET: BY INDICATION, CAGR (2022-2029)
FIGURE 27 U.S. UROLOGY DEVICES MARKET: BY INDICATION, LIFELINE CURVE
FIGURE 28 U.S. UROLOGY DEVICES MARKET: BY TECHNOLOGY, 2021
FIGURE 29 U.S. UROLOGY DEVICES MARKET: BY TECHNOLOGY, 2020-2029 (USD MILLION)
FIGURE 30 U.S. UROLOGY DEVICES MARKET: BY TECHNOLOGY, CAGR (2022-2029)
FIGURE 31 U.S. UROLOGY DEVICES MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 32 U.S. UROLOGY DEVICES MARKET: BY END USER, 2021
FIGURE 33 U.S. UROLOGY DEVICES MARKET: BY END USER, 2020-2029 (USD MILLION)
FIGURE 34 U.S. UROLOGY DEVICES MARKET: BY END USER, CAGR (2022-2029)
FIGURE 35 U.S. UROLOGY DEVICES MARKET: BY END USER, LIFELINE CURVE
FIGURE 36 U.S. UROLOGY DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 37 U.S. UROLOGY DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
FIGURE 38 U.S. UROLOGY DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 39 U.S. UROLOGY DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 40 U.S. UROLOGY DEVICES MARKET: COMPANY SHARE 2021 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.